K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar lancer009 (< 20) Submitted: 4/6/2011 2:59:48 AM : Outperform Start Price: $4.65 KV-A Score: -70.28

its just matter of time

Report this Post Reply

Featured Broker Partners


Advertisement